Increased serologic reactivity with automated CMIA testing and its implications for deceased donor eligibility determination in the United States
{{output}}
In the United States, the use of Food & Drug Administration (FDA)-licensed, approved, or cleared tests is required for infectious disease screening and determining the eligibility of deceased donors for all Human Cells, Tissues, and Cellular and Tissue-Based P... ...
